Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study
Pat Gulhati; Kanwal Raghav; Rachna T. Shroff; Gauri R. Varadhachary; Scott Kopetz; Milind Javle; Wei Qiao; Huamin Wang; Jeffrey Morris; Robert A. Wolff; Michael J. Overman
Author Information: Hematology/Oncology Fellowship Program, Division of Cancer Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.